ANSTO

Clipboard
26 June 2019

On Friday 21 June 2019, ARPANSA was notified of a radiation contamination event at the Australian Nuclear Science and Technology Organisation (ANSTO) Nuclear Medicine (ANM) production facility in Lucas Heights, New South Wales.

Clipboard icon with checkbox
27 May 2019

ARPANSA’s CEO, Dr Carl-Magnus Larsson has amended a licence issued to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine (ANM) facility.

Clipboard icon with checkbox
8 April 2019

ARPANSA has granted the Australian Nuclear Science and Technology Organisation (ANSTO) an amended license to allow for the limited production of molybdenum-99 in order to sustain supply.

Clipboard icon with checkbox
5 December 2018

On 4 December 2018, following a direction from ARPANSA’s CEO Dr Larsson, the Australian Nuclear Science and Technology Organisation (ANSTO) provided ARPANSA with an action plan that responds to 85

Clipboard icon with checkbox
22 October 2018

On 5 October 2018, following a direction from ARPANSA’s CEO Dr Carl-Magnus Larsson, the Australian Nuclear Science and Technology Organisation (ANSTO) provided ARPANSA with a report produced by an

Clipboard icon with checkbox
12 April 2018

ARPANSA’s CEO, Dr Carl-Magnus Larsson has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine Molybdenum-99 (Mo-99) Facility (the ANM Facility).

Man reading report
27 February 2018

On Monday 26 February 2018 a report by the CEO of ARPANSA, Dr Carl-Magnus Larsson, was tabled in Parliament addressing the radiation exposure of a worker at the Australian Nuclear Science and Technology Organisation (ANSTO) Health radiopharmaceuticals production facility at Lucas Heights.

Man reading report
26 February 2018

The matter considered in this report is a radiation exposure of a worker on 22 August 2017 at the Australian Nuclear Science and Technology Organisation (ANSTO) Health radiopharmaceuticals production facility at Lucas Heights, NSW, which exceeded the relevant statutory dose limit.

Subscribe to RSS - ANSTO